@article{3c2e03b7ddd643cba0cdda387b369e25,
title = "Intermediate-dose prophylactic anticoagulation with low molecular weight heparin is safe after bioprosthetic artificial heart implantation",
keywords = "Anticoagulants/adverse effects, Bioprosthesis/adverse effects, Blood Coagulation, Heart Valve Prosthesis Implantation, Heart, Artificial, Heparin, Heparin, Low-Molecular-Weight/adverse effects, Humans, anticoagulation, low molecular weight heparin, total artificial heart",
author = "Smadja, \{David M\} and Peter Ivak and Yuri Pya and Christian Latremouille and Finn Gustafsson and Roussel, \{Jean Christian\} and Andre Vincentelli and Erwan Flecher and Piet Jansen and Ivan Netuka",
year = "2022",
month = sep,
doi = "10.1016/j.healun.2022.05.017",
language = "English",
volume = "41",
pages = "1214--1217",
journal = "The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation",
issn = "1053-2498",
publisher = "Elsevier Inc.",
number = "9",
}